CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Phase II Study of the Antibody Drug Conjugate Trastuzumab-DM1 for the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2) –Positive Breast Cancer After Prior HER2-Directed Therapy
Authors
Barbara Klencke
Cabanillas F
+19 more
Chari RV
Charles L. Vogel
Elizabeth Tan-Chiu
Genentech
Hope S. Rugo
Howard A. Burris
Hynes NE
Ian E. Krop
Joyce A. O'Shaughnessy
Junttila T
Krop I
Lukas Amler
Maoxia Zheng
Rachel A. Borson
Richard A. Michaelson
Sandhya Girish
Steven Limentani
Svetislava J. Vukelja
Yu-Waye Chu
Publication date
Publisher
'American Society of Clinical Oncology (ASCO)'
Doi
Cite
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
info:doi/10.1200%2Fjco.2010.29...
Last time updated on 25/10/2020